Verastem, Inc. (VSTM) Financials

VSTM Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 206.5 million 156.5 million
March 31, 2026 227.8 million 146.0 million
Dec. 31, 2025 246.4 million 189.2 million
Sept. 30, 2025 176.9 million 192.4 million

VSTM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -43.9 million 3.4 million
March 31, 2026 -52.1 million 2.0 million
Dec. 31, 2025 -31.3 million 2.0 million
Sept. 30, 2025 -36.2 million 2.2 million

VSTM Net Income

No data available :(

VSTM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 136.4 million 75.9 million 2.6 million
March 31, 2026 181.7 million 76.9 million 2.8 million
Dec. 31, 2025 213.8 million 81.3 million 535000
Sept. 30, 2025 137.7 million 84.4 million 793000

VSTM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 100.1 million
March 31, 2026 99.1 million
Dec. 31, 2025 83.4 million
Sept. 30, 2025 73.2 million

VSTM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 41.3 million 27.4 million -
March 31, 2026 - 38.2 million 22.3 million -
Dec. 31, 2025 1.3 million 31.7 million 24.4 million -
Sept. 30, 2025 - 29.0 million 21.0 million -

VSTM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 40.1 million 4.0 million
March 31, 2026 18.7 million 3.1 million
Dec. 31, 2025 17.5 million 2.9 million
Sept. 30, 2025 11.2 million 1.7 million

VSTM Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VSTM

Price: $7.18

52 week price:
3.43
11.25

Earnings Per Share: -2.40 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 245000

Ebitda: -22.9 million

Market Capitalization: 629.4 million

Links: